QL
DNTH icon

Quarry LP’s Dianthus Therapeutics DNTH Stock Holding History

Quarry LP’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,400
Closed -$98.9K – 1644
2025
Q4 		$98.9K Buy
+2,400
New +$93K 0.02% 450
2025
Q3 		– Sell
-137
Closed -$2.55K – 2253
2025
Q2 		$2.55K Buy
+137
New +$2.57K ﹤0.01% 1559
2024
Q3 		– Sell
-33
Closed -$854 – 1742
2024
Q2 		$854 Buy
+33
New +$793 ﹤0.01% 1735

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Quarry LP's DNTH Position: Q1 2026 in Review

Quarry LP sold out of Dianthus Therapeutics (DNTH) in Q1 2026, closing a stake of 2,400 shares — an estimated $98.9K sold.

Quarry LP first reported a position in DNTH in Q2 2024 and held it in 3 quarters. The position peaked at $98.9K in Q4 2025. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Quarry LP reported no remaining Dianthus Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Quarry LP sold 2,400 Dianthus Therapeutics shares in Q1 2026, an estimated $98.9K.
  • Quarry LP first reported a position in Dianthus Therapeutics in Q2 2024 and held it in 3 quarters.
  • Quarry LP's Dianthus Therapeutics position peaked at $98.9K in Q4 2025.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Quarry LP's 13F filing for Q1 2026, filed 15 May 2026.